Fairvalue-Calculator Fairvalue-Calculator
EN DE

ViroGates A/S, an in vitro diagnostics company, (VIRO) Fair Value & Analysis

Healthcare · DK · Market cap 99.3M DKK

Pricekr 10.20
Fair Valuekr 9.41
Upside-7.7%
Quality95/100
Evidence: Low Range kr 7.06 – kr 11.76

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

ViroGates A/S, an in vitro diagnostics company, (VIRO) currently trades at kr 10.20, while our model-based Fair Value estimate is kr 9.41 — implying the stock looks roughly 7.7% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidimetric immunoassay for quantitative measurement of suPAR in human plasma; suPARnostic AUTO Flex ELISA kit, a fully quantitative immunoassay designed for accurate and reliable measurement of soluble urokinase plasminogen activator receptor in human plasma; and suPARnostic Quick Triage, a test for rapid, quantitative measurement of suPAR levels. ViroGates A/S was founded in 2000 and is headquartered in Birkerød, Denmark.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -9% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is ViroGates A/S, an in vitro diagnostics company, (VIRO) undervalued?
As of Jun 24, 2026, our model estimates a fair value of kr 9.41 versus a price of kr 10.20 — about −8% (overvalued). Model-based estimate, not financial advice.
What is the fair value of VIRO?
Our 21-model fair value for ViroGates A/S, an in vitro diagnostics company, is kr 9.41 (as of Jun 24, 2026), built from audited fundamentals. The current price is kr 10.20.
What is the quality score of VIRO?
ViroGates A/S, an in vitro diagnostics company, has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.